ISR stock forecast
Our latest prediction for IsoRay, Inc.'s stock price was made on the Nov. 15, 2018 when the stock price was at 0.39$.
In the short term (2weeks), ISR's stock price should outperform the market by 6.09%. During that period the price should oscillate between -8.05% and +17.86%.
In the medium term (3months), ISR's stock price should outperform the market by 9.75%. During that period the price should oscillate between -19.28% and +54.36%.Get email alerts
About IsoRay, Inc.
IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The company focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA.
At the moment the company generates 8M USD in revenues.
On its last earning announcement, the company reported a loss of -0.07$ per share.
The book value per share is 0.10$
Three months stock forecastNov. 15, 2018
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|